دورية أكاديمية

Aquaporin-4 IgG antibody-related disorders in patients with juvenile systemic lupus erythematosus.

التفاصيل البيبلوغرافية
العنوان: Aquaporin-4 IgG antibody-related disorders in patients with juvenile systemic lupus erythematosus.
المؤلفون: Moraitis, E, Stathopoulos, Y, Hong, Y, Al-Obaidi, M, Mankad, K, Hacohen, Y, Sen, D, Hemingway, C, Eleftheriou, D
المصدر: Lupus; 2019, Vol. 28 Issue 10, p1243-1249, 7p, 1 Black and White Photograph, 2 Charts
مصطلحات موضوعية: SYSTEMIC lupus erythematosus, TRANSVERSE myelitis, OPTIC neuritis, FISHER exact test
مستخلص: Objective: The aim of this study was to: (a) screen a large group of unselected patients with juvenile systemic lupus erythematosus for anti-aquaporin 4 antibodies (AQP4-Ab); (b) identify clinical and laboratory predictors of the presence of AQP4-Ab positivity in juvenile systemic lupus erythematosus. Methods: Sera from 90 patients with juvenile systemic lupus erythematosus were tested for the presence of AQP4-Ab using a cell-based assay. Demographics, clinical and immunological features, treatment received were summarized. Fisher's exact test was used to identify clinical predictors of positivity for AQP4-Ab. Results: Five of 90 (5.5%) patients tested positive for AQP4-Ab, all of which had neurological involvement, mainly transverse myelitis and optic neuritis. AQP4-Ab-positive patients were more likely to have neurological symptoms (P = 0.002), less likely to experience dermatological manifestations (P = 0.045), and less likely to have detectable anti-dsDNA antibodies (P = 0.022). These patients were also more likely to have received anti-epileptic (P = 0.023) and anti-coagulant (P = 0.007) drugs. Conclusions: The findings of this study indicate that some patients with juvenile systemic lupus erythematosus develop antibodies against aquaporin-4 and may be at risk of developing a neurological clinical phenotype. We suggest that all juvenile systemic lupus erythematosus patients should be systematically screened for the presence of AQP4-Ab and this may help identify a high risk for neurological involvement in juvenile systemic lupus erythematosus. [ABSTRACT FROM AUTHOR]
Copyright of Lupus is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:09612033
DOI:10.1177/0961203319855125